Neumora Therapeutics

NMRA

Börsenwert 80,6 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
101	101 Royal Bank of Canada Toronto, Ontario, Canada	6.000 $	+4.040 $	+2.122	+180 %
102	102 GF Fund Management Guangzhou, China	5.901 $	-506 $	-266	-7 %
103	103 Nisa Investment Advisors St. Louis, Missouri	2.492 $	–	–	–
104	104 State of Wyoming Cheyenne, Wyoming	2.266 $	+2.538 $	+1.333	Neu
105	105 Physician Wealth Advisors Midvale, Utah	2.244 $	–	–	–
106	106 PNC Financial Services Group Pittsburgh, Pennsylvania	1.700 $	–	–	–
107	107 Sterling Capital Management Charlotte, North Carolina	612 $	+685 $	+360	Neu
108	108 Parallel Advisors San Francisco, California	474 $	–	–	–
109	109 Caitong International Asset Management Hong Kong	442 $	+455 $	+239	+1.138 %
110	110 Optiver Holding Amsterdam, Netherlands	340 $	+381 $	+200	Neu
111	111 Arax Advisory Partners Denver, Colorado	245 $	+274 $	+144	Neu
112	112 Quarry LP New York	94 $	+105 $	+55	Neu
113	113 SBI Securities Tokyo, Japan	34 $	+4 $	+2	+11 %
114	114 Perceptive Advisors New York	–	-10 Mio. $	-5.104.097	Geschlossen
115	115 Adage Capital Partners Boston, Massachusetts	–	-1,95 Mio. $	-1.000.000	Geschlossen
116	116 Silverarc Capital Management Boston, Massachusetts	–	-1,6 Mio. $	-818.156	Geschlossen
117	117 Point72 Asset Management Stamford, Connecticut	–	-1,17 Mio. $	-602.403	Geschlossen
118	118 Franklin Resources San Mateo, California	–	-996.614 $	-511.084	Geschlossen
119	119 Tang Capital Management San Diego, California	–	-857.762 $	-439.878	Geschlossen
120	120 HRT Financial New York	–	-387.000 $	-198.851	Geschlossen
121	121 ExodusPoint Capital Management New York	–	-373.770 $	-191.677	Geschlossen
122	122 SkyOak Wealth Southfield, Michigan	–	-292.500 $	-150.000	Geschlossen
123	123 EntryPoint Capital New York	–	-216.206 $	-110.875	Geschlossen
124	124 Stonepine Capital Management Bend, Oregon	–	-190.380 $	-100.000	Geschlossen
125	125 Brevan Howard Capital Management St. Helier, Jersey	–	-189.296 $	-97.075	Geschlossen

Neumora Therapeutics NMRA Börsenwert 80,6 Mio. $

Neumora Therapeutics

NMRA

Börsenwert 80,6 Mio. $